February 24, 2014 Issue | Chemical & Engineering News
Copyright © 2014 American Chemical Society

February 24, 2014 Issue

Volume 92, Issue 8
February 24, 2014 Issue, Vol. 92 | Iss. 8
Low cost and impressive performance thrust new solar-cell technology into spotlight
By Mitch Jacoby
(pp. 10-16)
Researchers see a rocky path from genomics research to truly personalized medicines (pp. 18-23)
ACS News
Dallas, March 16–20 (p.46)
Back Issues

News of the Week

A Steric Strategy For Regioselective Arene Silylation

Rhodium catalyst adds silyl group to arenes to create valuable arylsilane intermediates

FDA Head Voices Concerns In India

Pharmaceuticals: On a visit to the country, Hamburg pushes for quality-control cooperation

Implantable Metal-Filled Particles Activate Cancer Drug

Oncology: Strategy restricts chemotherapeutic agent's toxicity in cells

Actavis Buys Forest Labs

Acquisition: Deal will create large specialty drug firm

Ashland Sells Water Technologies Business For $1.8 Billion

Restructuring: Activist investor pushed for divestment of underperforming assets

Beefing Up Refinery Regulations

Safety: California panel calls for inherently safer systems

Bendable Silicon Electronics

Materials: Exfoliation technique converts rigid silicon devices into flexible ones



Government & Policy

House legislation would force EPA to ignore most scientific data that aren’t available to the public
(pp. 28-29)
Administration moves forward with eight advanced manufacturing centers
(pp. 26-27)

Science & Technology

An octogenarian chemist’s latest invention turns hazardous aluminum mining waste into a material for cleaning up water
(pp. 33-35)
Low cost and impressive performance thrust new solar-cell technology into spotlight
(pp. 10-16)
A taste of who to see at chemistry’s Texas roundup
(pp. 36-37)

Editor's Page